Advancing Research

Advancing Research

Advancing Research

Keck Medicine of USC boasts a variety of prominent research programs in basic science, biomedical engineering, epidemiology, community health, and clinical research. Supporting and expanding a research enterprise of this magnitude requires funding for multiple priorities. Paramount among them is to attract still more visionary faculty members, particularly those with the experience that will allow them to collaborate across disciplines. The ability to offer endowed chairs and professorships, as well as laboratories, equipment, and support, is vital to this effort. 
 
Keck Medicine of USC has an outstanding track record of creating pioneering centers and institutes and supporting investigators who are expanding the frontiers of biomedical knowledge. These entities are critical for continuing the innovation that is defining the course for the health care revolution. Some notable examples include:
  • USC Norris Comprehensive Cancer Center 
  • Zilkha Neurogenetic Institute 
  • Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC  
  • National Science Foundation Engineering Research Center Devoted to Biomimetic Microelectronic Systems 
  • USC Institute for Health Promotion & Disease Prevention Research 
  • USC Institute for Global Health

Modern and adaptable facilities where faculty leaders and their laboratory teams can conduct their research also are vital. The planned Research Building III will be designed specifically to accommodate specialized and interdisciplinary research across a range of scientific and medical fields. 

Endowment and current-use funds are needed for emerging opportunities across the enterprise. Seed funds will jump-start early-stage research projects requiring proof of concept before they can attract external funding. And bridge funds will carry projects forward when federal and other sources of support are exhausted. The result will be the acceleration of scientific discoveries and their clinical applications, where they will more quickly reach the patients who need them most.